Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P56399

Entry ID Method Resolution Chain Position Source
AF-P56399-F1 Predicted AlphaFoldDB

50 variants for P56399

Variant ID(s) Position Change Description Diseaes Association Provenance
rs222313610 3 E>D No EVA
rs3388861961 16 I>F No EVA
rs3388861924 20 K>N No EVA
rs3388866802 46 C>Y No EVA
rs3388853728 58 V>M No EVA
rs249589399 79 P>L No EVA
rs3397309583 87 G>C No EVA
rs3388853800 97 T>I No EVA
rs3388861914 136 L>S No EVA
rs3396910520 146 R>W No EVA
rs3388844773 153 A>D No EVA
rs3388860927 169 W>* No EVA
rs3388857054 245 A>D No EVA
rs3388856998 245 A>T No EVA
rs3388863548 264 D>Y No EVA
rs3388858279 287 Q>R No EVA
rs3388863608 301 N>K No EVA
rs3388850461 303 R>W No EVA
rs3388841895 326 T>K No EVA
rs3388844735 364 N>S No EVA
rs3388841906 388 E>G No EVA
rs3388823608 403 P>L No EVA
rs228432918 404 E>D No EVA
rs3388863170 452 R>L No EVA
rs3388854371 463 F>L No EVA
rs3388862239 465 V>L No EVA
rs3388854297 484 D>V No EVA
rs3388863231 497 L>H No EVA
rs3388858332 517 V>M No EVA
rs3388858284 519 L>R No EVA
rs3388866739 523 V>A No EVA
rs3388866773 577 T>I No EVA
rs3396914332 601 Q>R No EVA
rs3388860851 624 P>S No EVA
rs3388861947 695 H>Q No EVA
rs3388841911 703 N>T No EVA
rs266234187 706 I>M No EVA
rs3388863218 711 S>I No EVA
rs241646899 724 P>S No EVA
rs3388862247 750 N>I No EVA
rs3397370929 756 V>E No EVA
rs3388866741 783 S>T No EVA
rs3388858318 787 S>Y No EVA
rs3388860413 791 G>E No EVA
rs3388853706 810 M>K No EVA
rs3397376323 813 S>Y No EVA
rs3388858312 819 Y>* No EVA
rs3388863168 822 H>Q No EVA
rs3388863184 831 I>T No EVA
rs3388857190 842 K>R No EVA

No associated diseases with P56399

9 regional properties for P56399

Type Name Position InterPro Accession
domain Peptidase C19, ubiquitin carboxyl-terminal hydrolase 326 - 853 IPR001394
domain Zinc finger, UBP-type 175 - 283 IPR001607
domain Ubiquitin-associated domain 654 - 695 IPR015940-1
domain Ubiquitin-associated domain 722 - 762 IPR015940-2
conserved_site Ubiquitin specific protease, conserved site 327 - 342 IPR018200-1
conserved_site Ubiquitin specific protease, conserved site 801 - 819 IPR018200-2
domain Ubiquitin specific protease domain 326 - 856 IPR028889
domain Ubiquitinyl hydrolase, variant UBP zinc finger 16 - 78 IPR041432
domain Ubiquitin carboxyl-terminal hydrolase 5, UBA1 domain 655 - 702 IPR041812

Functions

Description
EC Number 3.4.19.12 Omega peptidases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

4 GO annotations of molecular function

Name Definition
cysteine-type deubiquitinase activity An thiol-dependent isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated.
cysteine-type endopeptidase activity Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile.
ubiquitin binding Binding to ubiquitin, a protein that when covalently bound to other cellular proteins marks them for proteolytic degradation.
zinc ion binding Binding to a zinc ion (Zn).

4 GO annotations of biological process

Name Definition
positive regulation of proteasomal ubiquitin-dependent protein catabolic process Any process that activates or increases the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
protein deubiquitination The removal of one or more ubiquitin groups from a protein.
protein K48-linked deubiquitination A protein deubiquitination process in which a K48-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is removed from a protein.
ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.

5 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q92995 USP13 Ubiquitin carboxyl-terminal hydrolase 13 Homo sapiens (Human) PR
P45974 USP5 Ubiquitin carboxyl-terminal hydrolase 5 Homo sapiens (Human) PR
P57080 Usp25 Ubiquitin carboxyl-terminal hydrolase 25 Mus musculus (Mouse) SS
Q6A4J8 Usp7 Ubiquitin carboxyl-terminal hydrolase 7 Mus musculus (Mouse) PR
F6V6I0 usp13 Ubiquitin carboxyl-terminal hydrolase 13 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MAELSEEALL SVLPTIRVPK AGDRVHKDEC AFSFDTPESE GGLYICMNTF LGFGKQYVER
70 80 90 100 110 120
HFNKTGQRVY LHLRRTRRPK EEDTSAGTGD PPRKKPTRLA IGVEGGFDLT EDKFEFDEDV
130 140 150 160 170 180
KIVILPDYLE IARDGLGGLP DIVRDRVTSA VEALLSADSA SRKQEVQAWD GEVRQVSKHA
190 200 210 220 230 240
FNLKQLDNPA RIPPCGWKCS KCDMRENLWL NLTDGSILCG RRYFDGSGGN NHAVEHYRET
250 260 270 280 290 300
GYPLAVKLGT ITPDGADVYS YDEDDMVLDP SLAEHLSHFG IDMLKMQKTD KTMTELEIDM
310 320 330 340 350 360
NQRIGEWELI QESGVPLKPL FGPGYTGIRN LGNSCYLNSV VQVLFSIPDF QRKYVDKLEK
370 380 390 400 410 420
IFQNAPTDPT QDFSTQVAKL GHGLLSGEYS KPALESGDGE QVPEQKEVQD GIAPRMFKAL
430 440 450 460 470 480
IGKGHPEFST NRQQDAQEFF LHLINMVERN CRSSENPNEV FRFLVEEKIK CLATEKVKYT
490 500 510 520 530 540
QRVDYIMQLP VPMDAALNKE ELLEYEEKKR QAEEEKVPLP ELVRAQVPFS SCLEAYGAPE
550 560 570 580 590 600
QVDDFWSTAL QAKSVAVKTT RFASFPDYLV IQIKKFTFGL DWVPKKLDVS IEMPEELDIS
610 620 630 640 650 660
QLRGTGLQPG EEELPDIAPP LVTPDEPKGS LGFYGNEDED SFCSPHFSSP TSPMLDESVI
670 680 690 700 710 720
IQLVEMGFPM DACRKAVYYT GNSGAEAAMN WVMSHMDDPD FANPLILPGS SGPGSTSAAA
730 740 750 760 770 780
DPPPEDCVTT IVSMGFSRDQ ALKALRATNN SLERAVDWIF SHIDDLDAEA AMDISEGRSA
790 800 810 820 830 840
AESISESVPV GPKVRDGPGK YQLFAFISHM GTSTMCGHYV CHIKKEGRWV IYNDQKVCAS
850
EKPPKDLGYI YFYQRVVS